| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.5M | +436.5% |
| R&D Expense | $38.2M | -1.6% |
| SG&A Expense | $17.4M | +16.3% |
| Operating Income | -$52.6M | +1.0% |
| Income Tax | $0 | — |
| Net Income | -$80.4M | -55.2% |
| EPS (Basic) | -$2.65 | +76.0% |
| EPS (Diluted) | -$2.65 | +76.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $109.5M | +71.0% |
| Current Assets | $114.1M | +71.9% |
| Total Assets | $117.8M | +50.4% |
| Current Liabilities | $15.5M | +61.6% |
| Total Liabilities | $70.1M | +362.3% |
| Stockholders' Equity | $47.7M | -24.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$29.6M | +35.1% |
| Capital Expenditures | $279K | -36.7% |
| Investing Cash Flow | -$243K | +44.9% |
| Financing Cash Flow | $75.9M | +5.9% |
| Free Cash Flow | -$29.8M | +35.2% |